A.T.A. Fazekas

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

G. Tolis, DCF ACKMAN, A. Stellos et al. · Proceedings of the National Academy of Sciences · 1982 · 368 citations · Full text

Medicine, Endocrinology, Urology +14

New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens

Fernand Labrie, A. Dupont, A. Bèlanger et al. · The Prostate · 1983 · 292 citations

Medicine, Oncology, Pharmacology +16

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

Fernand Labrie, A. Dupont, A. Bèlanger et al. · PubMed · 1982 · 274 citations

Medicine, Endocrinology, Pharmacology +14

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

André Lemay, Rodolphe Maheux, Nacia Faure et al. · Fertility and Sterility · 1984 · 213 citations

Medicine, Endocrinology, Pharmacology +16

Ketoconazole in the Management of Precocious Puberty Not Responsive to LHRH-Analogue Therapy

F John Holland, Leona Fishman, John D. Bailey et al. · New England Journal of Medicine · 1985 · 111 citations

Medicine, Endocrinology, Pharmacology +17